| 83703-048 | Heplisav-b | Hepatitis B Vaccine (recombinant) Adjuvanted | Injection, Solution | Intramuscular | Vaccine | ACTIVE |
| 83703-083 | Fluzone Trivalent Northern Hemisphere | Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136/rv/2023 (h3n2) Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) | Injection, Suspension | Intramuscular | Vaccine | ACTIVE |
| 83703-084 | Flucelvax | Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/victoria/800/2024 Cvr-289 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated) | Injection, Suspension | Intramuscular | Vaccine | ACTIVE |
| 83703-085 | Recombivax Hb | Hepatitis B Vaccine (recombinant) | Injection, Suspension | Intramuscular; Subcutaneous | Vaccine | ACTIVE |
| 83703-086 | Recombivax Hb | Hepatitis B Vaccine (recombinant) | Injection, Suspension | Intramuscular; Subcutaneous | Vaccine | ACTIVE |
| 83703-549 | Cyclophosphamide | Cyclophosphamide | Injection, Powder, For Solution | Intravenous; Oral | Human Prescription Drug | ACTIVE |
| 83703-550 | Cyclophosphamide | Cyclophosphamide | Injection, Powder, For Solution | Intravenous; Oral | Human Prescription Drug | ACTIVE |
| 83703-551 | Cyclophosphamide | Cyclophosphamide | Injection, Powder, For Solution | Intravenous; Oral | Human Prescription Drug | ACTIVE |
| 83703-559 | Mesnex | Mesna | Injection, Solution | Intravenous | Human Prescription Drug | ACTIVE |
| 83703-037 | Flucelvax Quadrivalent | | | | | |
| 83703-038 | Hyqvia | | | | | |
| 83703-039 | Hyqvia | | | | | |
| 83703-040 | Hyqvia | | | | | |
| 83703-041 | Hyqvia | | | | | |
| 83703-042 | Hyqvia | | | | | |
| 83703-043 | M-m-r Ii | | | | | |
| 83703-044 | Fluzone Quadrivalent Northern Hemisphere | | | | | |
| 83703-061 | Fluzone Trivalent | | | | | |
| 83703-062 | Flucelvax | | | | | |
| 83703-079 | Fluzone Quadrivalent Northern Hemisphere | | | | | |
| 83703-080 | Fluzone Trivalent Southern Hemisphere | | | | | |
| 83703-001 | | Choriogonadotropin Alfa | Injection, Powder, Lyophilized, For Solution | | Drug For Further Processing | UNFINISHED |
| 83703-511 | | Zolbetuximab | Injection | | Drug For Further Processing | UNFINISHED |
| 83703-516 | | Zolbetuximab | Injection | | Drug For Further Processing | UNFINISHED |
| 83703-530 | | Datopotamab Deruxtecan | Injection | | Drug For Further Processing | UNFINISHED |
| 83703-563 | | Paclitaxel | Injection, Powder, Lyophilized, For Suspension | | Drug For Further Processing | UNFINISHED |
| 83703-564 | | Brentuximab Vedotin | Powder, For Solution | | Drug For Further Processing | UNFINISHED |
| 83703-567 | | Busulfan | Injection | | Drug For Further Processing | UNFINISHED |
| 83703-568 | | Mecasermin | Injection, Solution | | Drug For Further Processing | UNFINISHED |
| 83703-569 | | Mecasermin | Injection, Solution | | Drug For Further Processing | UNFINISHED |
| 83703-570 | | Enfortumab Vedotin | Injection, Powder, Lyophilized, For Solution | | Drug For Further Processing | UNFINISHED |
| 83703-571 | | Enfortumab Vedotin | Injection, Powder, Lyophilized, For Solution | | Drug For Further Processing | UNFINISHED |
| 83703-572 | | Choriogonadotropin Alfa | Injection, Powder, Lyophilized, For Solution | | Drug For Further Processing | UNFINISHED |
| 83703-573 | | Rituximab-arrx | Injection, Solution | | Drug For Further Processing | UNFINISHED |
| 83703-574 | | Rituximab-arrx | Injection, Solution | | Drug For Further Processing | UNFINISHED |
| 83703-575 | | Rituximab-arrx | Injection, Solution | | Drug For Further Processing | UNFINISHED |
| 83703-576 | | Rituximab-arrx | Injection, Solution | | Drug For Further Processing | UNFINISHED |
| 83703-577 | | Temozolomide | Injection, Powder, Lyophilized, For Solution | | Drug For Further Processing | UNFINISHED |
| 83703-578 | | Tisotumab Vedotin | Injection, Powder, For Solution | | Drug For Further Processing | UNFINISHED |
| 83703-579 | | Tisotumab Vedotin | Injection, Powder, For Solution | | Drug For Further Processing | UNFINISHED |
| 83703-580 | | Trastuzumab Deruxtecan | Injection, Powder, Lyophilized, For Solution | | Drug For Further Processing | UNFINISHED |
| 83703-581 | | Rituximab-abbs | Injection, Solution, Concentrate | | Drug For Further Processing | UNFINISHED |
| 83703-582 | | Rituximab-abbs | Injection, Solution, Concentrate | | Drug For Further Processing | UNFINISHED |
| 83703-583 | | Lurbinectedin | Injection, Powder, Lyophilized, For Solution | | Drug For Further Processing | UNFINISHED |